P&G to Acquire Thorne for $3.8B

Acquisition Overview

Procter & Gamble Co. has reached an agreement to acquire supplement maker Thorne for a total consideration of $3.8 billion. The transaction is slated to be formally announced later today.

Target Company Profile

Thorne, established in 1984, manufactures a diverse portfolio of health‑supplement products ranging from creatine to prenatal vitamins. In 2023, the company was taken private for $680 million by private‑equity firm L Catterton, which is backed by luxury‑goods conglomerate LVMH. According to CNBC, Thorne is on track to generate $650 million in total sales for the fiscal year 2026.

Market Context and Prior Interest

Prior to P&G’s bid, the acquisition of Thorne had been the subject of speculation for several months. The Financial Times reported that UK‑based companies Haleon Plc and Unilever Plc were also identified as potential buyers.

Stock Reaction

Following the news, P&G’s share price rose 2.02 %, reflecting market optimism about the strategic fit of the acquisition.